Mirum Pharmaceuticals, Inc. MIRM Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $261.46M+2.8% | $254.38M+10.5% | $230.14M+22.2% | $188.37M+3.4% | $182.26M-10.2% | ||
| $61.35M-29.2% | $86.64M-7.4% | $93.53M+22.4% | $76.43M+16.1% | $65.85M— | ||
| $133.11M+7.9% | $123.33M+15.1% | $107.13M+0.3% | $106.84M+11.5% | $95.85M+22.4% | ||
| $97.37M+3.3% | $94.27M+2.7% | $91.78M+2.7% | $89.36M+2.9% | $86.85M+0.9% | ||
| $569.44M+3.6% | $549.68M+3.6% | $530.58M+17.0% | $453.4M+10.4% | $410.82M+4.6% | ||
| $2.41M+29.5% | $1.86M+45.8% | $1.28M+8.5% | $1.18M+6.2% | $1.11M-2.7% | ||
| $254.15M-2.6% | $260.92M+12.5% | $231.9M-2.5% | $237.87M-2.5% | $243.85M-2.4% | ||
| $890.92M+5.7% | $842.81M+7.3% | $785.12M+8.2% | $725.83M+5.2% | $690.25M+2.9% | ||
| $59.4M+518% | $9.61M-21.0% | $12.17M-31.1% | $17.66M+51.7% | $11.64M-20.4% | ||
| $272.82M+32.6% | $205.8M+28.3% | $160.36M+10.7% | $144.8M+13.5% | $127.58M+0.8% | ||
| $648.42M+22.8% | $528.12M+7.1% | $493.07M+4.8% | $470.67M+3.0% | $456.99M+2.7% | ||
| 200M0.0% | 200M0.0% | 200M0.0% | 200M0.0% | 200M+3,999,900% | ||
| -$1.46B-118% | -$667.54M-0.9% | -$661.81M+0.4% | -$664.72M-0.9% | -$658.86M-2.3% | ||
| $242.49M-22.9% | $314.69M+7.8% | $292.05M+14.5% | $255.16M+9.4% | $233.26M+3.4% | ||
| $890.92M+5.7% | $842.81M+7.3% | $785.12M+8.2% | $725.83M+5.2% | $690.25M+2.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Mirum Pharmaceuticals, Inc.'s total assets?
- Mirum Pharmaceuticals, Inc. (MIRM) holds $890.9M in total assets, up 29.1% year over year.
- How much debt does Mirum Pharmaceuticals, Inc. have?
- Mirum Pharmaceuticals, Inc. carries $13.5M in total debt against $242.5M of shareholders' equity, a debt-to-equity ratio of 0.06.
- How much cash does Mirum Pharmaceuticals, Inc. have?
- Mirum Pharmaceuticals, Inc. holds $261.5M in cash and equivalents.
- Can Mirum Pharmaceuticals, Inc. cover its short-term obligations?
- Its current ratio is 2.09 — current assets exceed current liabilities.
- Where does Mirum Pharmaceuticals, Inc.'s balance sheet data come from?
- Every line is extracted from Mirum Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
